GANDHI T, SINGH A, PATEL A, KARIA P, SHAH H. Sodium current inhibitor ranolazine ameliorates experimentally induced diabetic cardiomyopathy. J.Res.Pharm. 2020; 24(6): 842-854. http://dx.doi.org/10.35333/jrp.2020.243